These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24180)

  • 21. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K
    J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of cyclophosphamide on antibody formation in the mouse.
    Willers JM; Sluis E
    Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of splenectomy on graft-versus-host disease (GVHD) in mice.
    Glucksberg H; Fefer A
    J Reticuloendothel Soc; 1972 Nov; 12(5):537-44. PubMed ID: 4120362
    [No Abstract]   [Full Text] [Related]  

  • 24. Demonstration of cell mediated autoimmunity and induction of a suppressive control mechanism.
    L'age-Stehr J; Diamantstein T; Teichmann H
    Adv Exp Med Biol; 1979; 114():327-32. PubMed ID: 463648
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased graft-versus-host response of parental-strain (donor) lymphoid cells in cyclophosphamide-treated F1 recipients.
    Wander RH; Derlet RW; Hilgard HR
    Cell Immunol; 1976 Feb; 21(2):250-6. PubMed ID: 4228
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of intrasplenic injection of parental splenocytes on systemic graft-versus-host reaction in adult F1 mice pretreated with cyclophosphamide.
    Skowron-Cendrzak A; Rybczyńska Z; Krawiec M; Jurkiewicz A
    Folia Biol (Krakow); 1985; 33(1-2):73-82. PubMed ID: 4076469
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of cyclosporin on lymphocyte activation in a systemic graft-vs.-host reaction.
    Chisholm PM; Drayson MT; Cox JH; Ford WL
    Eur J Immunol; 1985 Oct; 15(10):1054-9. PubMed ID: 3876941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The induction and abolition of specific immunosuppression of heart allografts in rats by use of donor blood and cyclophosphamide.
    Marquet R; Heystek G
    J Immunol; 1975 Aug; 115(2):405-8. PubMed ID: 239060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered immunological reactivity in rats sustaining a graft-versus-host-reaction (GvHR).
    Lang P; Charpentier B; Martin B; Fries D
    Adv Exp Med Biol; 1982; 149():553-61. PubMed ID: 6216770
    [No Abstract]   [Full Text] [Related]  

  • 30. [Participation of mouse T- and B-lymphocytes in the graft versus host reaction].
    Bliakher MS
    Biull Eksp Biol Med; 1976 Jun; 81(6):713-5. PubMed ID: 8176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased mortality of murine graft-versus-host disease by human chorionic gonadotropin.
    Slater LM; Bostick W; Fletcher L
    Transplantation; 1977 Jan; 23(1):103-4. PubMed ID: 13524
    [No Abstract]   [Full Text] [Related]  

  • 32. Desensitization in vitro: the role of T-suppressor cells, T-suppressor factor and T-acceptor cells in the inhibition of the passive transfer of contact sensitivity to picryl chloride by exposure to antigen in vitro.
    Zembala M; Asherson GL; Colizzi V; Watkins MC
    Immunology; 1982 Dec; 47(4):605-15. PubMed ID: 6216199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro.
    Shand FL
    Immunology; 1978 Dec; 35(6):1017-25. PubMed ID: 33118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amplification of the graft-versus-host reaction by cyclophosphamide: dependence on timing of drug administration.
    Lehnert S; Rybka WB
    Bone Marrow Transplant; 1994 Apr; 13(4):473-7. PubMed ID: 8019473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early increase in graft-versus-host reactivity during pregnancy in the mouse.
    Piazzón I; Matusevich M; Déroche A; Nepomnaschy I; Pasqualini CD
    J Reprod Immunol; 1985 Nov; 8(2-3):129-37. PubMed ID: 3879270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of kupffer cells and suppressor T cells in the graft versus host reaction after intrahepatic lymphoid tissue implantation.
    Vuitton D; Eloy R; Clendinnen G; Grenier JF
    Cell Immunol; 1977 Nov; 34(1):138-45. PubMed ID: 21033
    [No Abstract]   [Full Text] [Related]  

  • 37. FTY720, a novel immunosuppressant, possessing unique mechanisms. IV. Prevention of graft versus host reactions in rats.
    Masubuchi Y; Kawaguchi T; Ohtsuki M; Suzuki C; Amano Y; Hoshino Y; Chiba K
    Transplant Proc; 1996 Apr; 28(2):1064-5. PubMed ID: 8623228
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of manganese dichloride on the graft vs host activity of splenic lymphocytes in mice].
    Divanian Kh; Boshnakova E
    Eksp Med Morfol; 1988; 27(4):17-9. PubMed ID: 3266148
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ways of controlling reactions attributable to non-syngenous immunocompetent cells].
    Kaulen DR; Maianskiĭ DN
    Usp Sovrem Biol; 1977; 84(4):38-52. PubMed ID: 27024
    [No Abstract]   [Full Text] [Related]  

  • 40. An active suppressor mechanism preventing skin allograft rejection in mice.
    Kilshaw PJ; Brent L; Pinto M
    Transplant Proc; 1975 Jun; 7(2):225-8. PubMed ID: 48301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.